Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_07b71571160c289fbf5fc680dfea513f |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-415 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4178 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 |
filingDate |
1998-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_00389fefd2220435cc2a7af97889f561 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_db85408cffe49821ecd4dc8b4c0c1d79 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_92859859995f1fd4e50bedac2f32a90a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4e52f69d93a3f271cacd885394faae40 |
publicationDate |
2000-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CO-4960666-A1 |
titleOfInvention |
NEUTRALIZATION OF LOADS WITH ARGINYL OF EPRO-SARTAN AND A PROCEDURE FOR ITS PRODUCTION AND FORMULATION |
abstract |
A compound that is an arginyl charge neutralization complex of (E) -a- [2-n-butyl-1 - [(4- carboxy-phenyl) methyl] -1H-imidazol-5-yl] methylene-2 -thiophene-propionic. A process for the preparation of the composition according to claim 5, comprising: (i) mixing the (E) -a- [2-n-butyl-1 - [(4-carboxyphenyl) methyl] -1H- acid imidazol-5-yl] methylene-2-thiophene-propionic acid or its methanesulfonate salt and L-arginine with one or more pharmaceutically acceptable carriers. (ii) granulate the mixture with water; and (iii) drying the granulate to a predetermined water content. 5A pharmaceutical composition comprising (E) -a- [2-n-butyl-1 - [(4-carboxyphenyl) methyl] -1H-imidazol-5-yl] methylene-2-thiophene-propionic acid or its methanesulfonate salt, a charge neutralizing complexing agent and a pharmaceutically acceptable carrier. |
priorityDate |
1997-08-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |